GLP-1 drugs linked to delayed wound healing after aesthetic and body-contouring surgery, review of 29,000 patients finds
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
Actor John Goodman has lost about 14 stone, roughly half his body weight, over many years.
On 7 October 2026 WHO released its first global guidelines on caring for children and adolescents with obesity.
A Danish registry study analysed 756,636 pregnancies, 529 with possible exposure to semaglutide or liraglutide around conception.
In two phase 3 trials with more than 1,000 patients, the experimental drug retatrutide cut knee osteoarthritis pain by at least half in about two-thirds of people, versus 38% on placebo.
On 17 November 2026 WHO, UNICEF and Spain launched the call to action “Bending the curve by 2030”.
Allergan Aesthetics (AbbVie) presented 9 abstracts at ASDS 2026 in San Diego (5–8 November).
Australia's Therapeutic Goods Administration has approved a once-daily oral tablet form of semaglutide, sold as Wegovy.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one vial of NAD+ injection because their sterility cannot be assured.
Galderma, L'Oréal and Natura are testing treatments for facial sagging and volume loss in weight-loss drug users.
Nothing more to show